News

Weight-loss jab Wegovy sees another prescription boost after ban on copycats
Novo Nordisk’s weight loss drug, Wegovy, is experiencing a surge in new prescriptions following a US ban on its copycat ...
Medical Writing Market Trends & Forecast Report 2025-2033 | Clinical Trials Surge Escalates Demand, Increased Regulatory Needs Fuel Growth
The global medical writing market is projected to grow from USD 4.66 billion in 2024 to USD 12.12 billion by 2033, with a CAGR of 11.20% from 2025 to 2033. This growth is driven by the expansion of ...
Patient Registry Software Market worth $3.61 billion by 2030 with 9.8% CAGR | MarketsandMarkets™
The global Patient Registry Software Market, valued at US$2.06 billion in 2024 stood at US$2.25 billion in 2025 and is ...
Patient Registry Software Market worth $3.61 billion by 2030 with 9.8% CAGR | MarketsandMarkets
The global Patient Registry Software Market, valued at US$2.06 billion in 2024 stood at US$2.25 billion in 2025 and is projected to advance ...
IQVIA Holdings Inc. stock outperforms competitors on strong trading day
Shares of IQVIA Holdings Inc. IQV climbed 17.88% to $187.38 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to ...